» Articles » PMID: 23700468

Eosinophils Promote Epithelial to Mesenchymal Transition of Bronchial Epithelial Cells

Abstract

Eosinophilic inflammation and remodeling of the airways including subepithelial fibrosis and myofibroblast hyperplasia are characteristic pathological findings of bronchial asthma. Epithelial to mesenchymal transition (EMT) plays a critical role in airway remodelling. In this study, we hypothesized that infiltrating eosinophils promote airway remodelling in bronchial asthma. To demonstrate this hypothesis we evaluated the effect of eosinophils on EMT by in vitro and in vivo studies. EMT was assessed in mice that received intra-tracheal instillation of mouse bone marrow derived eosinophils and in human bronchial epithelial cells co-cultured with eosinophils freshly purified from healthy individuals or with eosinophilic leukemia cell lines. Intra-tracheal instillation of eosinophils was associated with enhanced bronchial inflammation and fibrosis and increased lung concentration of growth factors. Mice instilled with eosinophils pre-treated with transforming growth factor(TGF)-β1 siRNA had decreased bronchial wall fibrosis compared to controls. EMT was induced in bronchial epithelial cells co-cultured with human eosinophils and it was associated with increased expression of TGF-β1 and Smad3 phosphorylation in the bronchial epithelial cells. Treatment with anti-TGF-β1 antibody blocked EMT in bronchial epithelial cells. Eosinophils induced EMT in bronchial epithelial cells, suggesting their contribution to the pathogenesis of airway remodelling.

Citing Articles

Type 2 immunity in allergic diseases.

Ogulur I, Mitamura Y, Yazici D, Pat Y, Ardicli S, Li M Cell Mol Immunol. 2025; 22(3):211-242.

PMID: 39962262 PMC: 11868591. DOI: 10.1038/s41423-025-01261-2.


Epithelial-mesenchymal transition in asthma: its role and underlying regulatory mechanisms.

Zhang B, Feng X, Tian L, Xiao B, Hou L, Mo B Front Immunol. 2025; 16:1519998.

PMID: 39911398 PMC: 11794105. DOI: 10.3389/fimmu.2025.1519998.


Co-Stimulation with TWEAK and TGF-β1 Induces Steroid-Insensitive TSLP and CCL5 Production in BEAS-2B Human Bronchial Epithelial Cells.

Abe S, Harada N, Sandhu Y, Sasano H, Tanabe Y, Ueda S Int J Mol Sci. 2024; 25(21).

PMID: 39519176 PMC: 11546882. DOI: 10.3390/ijms252111625.


Eosinophil-Epithelial Cell Interactions in Asthma.

Steffan B, Townsend E, Denlinger L, Johansson M Int Arch Allergy Immunol. 2024; 185(11):1033-1047.

PMID: 38885626 PMC: 11534548. DOI: 10.1159/000539309.


The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma.

Nakagome K, Nagata M Biomolecules. 2024; 14(5).

PMID: 38785953 PMC: 11117569. DOI: 10.3390/biom14050546.


References
1.
Rothenberg M . Eosinophilia. N Engl J Med. 1998; 338(22):1592-600. DOI: 10.1056/NEJM199805283382206. View

2.
Yasui H, Gabazza E, Tamaki S, Kobayashi T, Hataji O, Yuda H . Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med. 2001; 163(7):1660-8. DOI: 10.1164/ajrccm.163.7.9911068. View

3.
Minshall E, Leung D, Martin R, Song Y, Cameron L, Ernst P . Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 1997; 17(3):326-33. DOI: 10.1165/ajrcmb.17.3.2733. View

4.
Wilson M, Wynn T . Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2009; 2(2):103-21. PMC: 2675823. DOI: 10.1038/mi.2008.85. View

5.
Wynn T . Cellular and molecular mechanisms of fibrosis. J Pathol. 2007; 214(2):199-210. PMC: 2693329. DOI: 10.1002/path.2277. View